Did some digging into NCI funded R01s for ESI/NI applicants in 2020/21 (based on 50 randomly samples funded awards). Comments @theNCI @NCIDirector @NIHDirector @NIHFunding. Be warned if you're a non-white female ESI PhD @NewPI_Slack @FuturePI_Slack #AcademicChatter

Truth

So when Trump fires all non-partisan career professionals in government, replaces them with radical loyalists within every nook and cranny of the US government, and adds radical judges everywhere. And every one of you that voted for him finally wake up from your fucked up

To my science framily, As we reflect on this election season, I want to take a moment to acknowledge that things may not have gone as we had hoped or expected. I wish I was shocked that America did not elect its first woman and woman of color to the presidency but I am angry and

Always be my Madam President

Thanks to my amazing grad student (Megha Raghunathan @sbpdiscovery @SBPCancerCenter ) and postdoc (Tyler DeWitt) #NotOnHere who made the figures, wrote the paper, and read about a billion papers to provide insight into new directions for research into DNA repair and cancer

What do DNA repair proteins do in cancer cells? Repair DNA? Yes! Regulate cell cycle? Maybe you've read about that somewhere? Alter autophagy? Wait, what! Read all about it on our review here https://t.co/IZAIfE1P6A @trendscancer [Our first paper from @SDSU]

This #BreastCancerAwarenessMonth, we celebrate the invaluable work that @TouchBBCA is doing to get Black women to participate in #BreastCancer #ClinicalTrials. Listen to our conversation with Ricki Fairley, CEO of TOUCH and breast cancer survivor: https://t.co/l2F2Wyxl2h

Excited for this conference. Register today. It's a lovely mix of basic, translational and clinical perspectives on cancer research

Bit late on this (was published end of last year) but came across this interesting paper @eLife using chatGPT to look at bias in peer review language based on gender, i.e. what was the tone of the review? Ans: people are ruder to women. Neat study. https://t.co/uEwK64TYI1

The American I chose to become a citizen of

Retweet if you LOVE this!

I feel like I could hear Ashi, @MeliD32, Shine Chang, and so many other scientists I look up to saying those words to junior scientists rising up the ranks: walk into a room as if we are all in there with you, but that means we expect you to not be silent ✊🏾🔥

I can't explain how excited I am!!!

First paper of 2024 🚨: Macrophages coordinate healing in aneurysms through VEGF! Four commercial devices were tested - and they look different when you get up close and personal 👀 We asked: how does this change immune healing in aneurysms? Paper: https://t.co/aeUzrs2pXT

Rooting for Team SAMBAI

Fabulous time at the @ACS_Research San Diego gala with @svastiharichar1 @BrookeEmerling and Anindya Bagchi. Thank you American Cancer Society for supporting our research. @SBPCancerCenter

Our review “The uncharted role of HER2 mutant alleles in breast cancer” in now online. @RashiKalra49, @naborala, @DrMJELLIS @Oncotarget Link, https://t.co/LvpGnBwmM6

Cool new study. DNA repair and endo resistance, there's a lot left to unpack

Fantastic work by @PassosLab @HSalmonowicz @MitosRUs and others. Thanks for including us. Now we have at least 3 cytoplasmic DNAs to think about in senescence- Line1, CCF and mitochondrial. What’s the relationship between them?

Today's Nobel is a reminder to focus on the work and not the journal. The key publications cited by the committee were published in Immunity, Molecular Therapy, and Nucleic Acids Research. Respectable journals, but not the Big 3. The discoveries are what's important, not a name.